Also trades as: OACC (NASDAQ) · $vol 0M
OACCW NASDAQ
Oaktree Acquisition Corp. III Life Sciences
1W: -14.7%
1M: +3.9%
3M: +3.9%
YTD: -14.7%
$0.81
-0.13 (-13.82%)
Weekly Expected Move ±19.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$227.3M
52W Range0.8101-0.99
Volume4
Avg Volume2,661
Beta0.24
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZaid Pardesi
Employees1,500
SectorFinancial Services
IndustryShell Companies
IPO Date2025-10-06
333 South Grand Avenue
Los Angeles, CA 90071
US
Los Angeles, CA 90071
US
213 830 6300
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences presently lacks significant commercial operations. Its primary focus is on completing a business combination, which could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization, or a similar corporate transaction, with one or more entities. The company aims to identify and acquire businesses operating in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors across North America and Europe. Incorporated in 2024, its base of operations is in Los Angeles, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Martinez George Arth | 0 | — | 2025-10-29 | |
| BERRY DAVID A | 0 | — | 2025-10-17 | |
| Sweeney Thomas | 0 | — | 2025-06-03 | |
| Oaktree Acquisition | J-Other | 231,492 | — | 2024-10-30 |
| Oaktree Acquisition | C-Conversion | 33,981 | $10.00 | 2024-10-30 |